Literature DB >> 1545388

Colchicine-specific Fab fragments alter colchicine disposition in rabbits.

A E Sabouraud1, M Urtizberea, N J Cano, M Grandgeorge, J M Rouzioux, J M Scherrmann.   

Abstract

High-affinity goat antibodies and Fab fragments (Ka = 1.1 x 10(10) M(-1) specific to colchicine were prepared to study their effect on colchicine pharmacokinetics in rabbits. First, colchicine disposition kinetics were investigated in four control rabbits after administration of 0.1 mg/kg i.v. Total and free plasma and urine colchicine were assayed by specific radioimmunoassay. The mean elimination half-life of total plasma colchicine was 16 +/- 2.9 h. Colchicine has a large volume of distribution (8.8 +/- 1.8 l/kg) and a low systemic clearance (114.6 +/- 3.4 ml.h-1.kg-1). Renal clearance represented 30.7 +/- 1.9% of total body clearance. The free plasma colchicine fraction was 70% after equilibrium dialysis. Second, 1.5 h after injection of 0.1 mg/kg colchicine, four rabbits were infused over 0.25 h with colchicine-specific Fab fragments at a half-stoichiometrically equivalent dose compared to the colchicine dose. Within 15 min after Fab infusion, total colchicine concentrations increased 10- to 16-fold. Mean area under the plasma concentration-time curves increased 20-fold compared to controls. The free plasma fraction decreased to an undetectable level over a period of 2 h. The Fab fragment administration also produced, respectively, a 24- and 17-fold decrease in the volume of distribution and systemic clearance. Colchicine recovered in urine was significantly higher than in the control group: 44.7 +/- 2.3 and 30.9 +/- 2% of the dose, respectively (P less than .05). These data suggest that high-affinity colchicine-specific Fab fragments can sequestrate and extract colchicine from tissues to the vascular compartment with subsequent colchicine excretion by the renal route.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1545388

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Monoclonal digoxin-specific antibodies induce dose- and affinity-dependent plasma digoxin redistribution in rats.

Authors:  N J Cano; A E Sabouraud; K Benmoussa; F Roquet; I Navarro-Teulon; J C Mani; J M Scherrmann
Journal:  Pharm Res       Date:  1995-05       Impact factor: 4.200

Review 2.  Fab antibody fragments: some applications in clinical toxicology.

Authors:  Robert J Flanagan; Alison L Jones
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

3.  A mechanism-based binding model for the population pharmacokinetics and pharmacodynamics of omalizumab.

Authors:  Naoto Hayashi; Yuko Tsukamoto; William M Sallas; Philip J Lowe
Journal:  Br J Clin Pharmacol       Date:  2006-11-10       Impact factor: 4.335

4.  Development of a sensitive radioimmunoassay for Fab fragments: application to Fab pharmacokinetics in humans.

Authors:  C V Thanh-Barthet; M Urtizberea; A E Sabouraud; N J Cano; J M Scherrmann
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

Review 5.  Clinical review: aggressive management and extracorporeal support for drug-induced cardiotoxicity.

Authors:  Frédéric J Baud; Bruno Megarbane; Nicolas Deye; Pascal Leprince
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

6.  Unraveling the pharmacokinetic interaction of ticagrelor and MEDI2452 (Ticagrelor antidote) by mathematical modeling.

Authors:  J Almquist; M Penney; S Pehrsson; A-S Sandinge; A Janefeldt; S Maqbool; S Madalli; J Goodman; S Nylander; P Gennemark
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-06-16

7.  Anti-colchicine Fab fragments prevent lethal colchicine toxicity in a porcine model: a pharmacokinetic and clinical study.

Authors:  Michael Eddleston; Nicolas Fabresse; Adrian Thompson; Ibrahim Al Abdulla; Rachael Gregson; Tim King; Alain Astier; Frederic J Baud; R Eddie Clutton; Jean-Claude Alvarez
Journal:  Clin Toxicol (Phila)       Date:  2018-01-15       Impact factor: 4.467

8.  A rare case report of heavy dose colchicine induced acute kidney injury.

Authors:  Hongzhen Zhong; Zhiqing Zhong; Hongyan Li; Tianbiao Zhou; Weiji Xie
Journal:  BMC Pharmacol Toxicol       Date:  2018-10-30       Impact factor: 2.483

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.